The Application of Radiolabeled Targeted Molecular Probes for the Diagnosis and Treatment of Prostate Cancer-Reference-Cited by-同舟云学术

The Application of Radiolabeled Targeted Molecular Probes for the Diagnosis and Treatment of Prostate Cancer

Published:2023 Issue:6 Volume:24 Page:574
ISSN:1229-6929
Container-title:Korean Journal of Radiology
language:en
Short-container-title:Korean J Radiol

Author:

Cheng Luyi¹^ORCID,Yang Tianshuo¹^ORCID,Zhang Jun²^ORCID,Gao Feng³^ORCID,Yang Lingyun⁴^ORCID,Tao Weijing¹^ORCID

Affiliation:

1. Department of Nuclear Medicine, The Affiliated Huaian No. 1 People’s Hospital of Nanjing Medical University, Huai’an, Jiangsu, China.

2. Department of Nuclear Medicine, The Affiliated Taizhou People’s Hospital of Nanjing Medical University, Taizhou, Jiangsu, China.

3. Key Laboratory for Experimental Teratology of the Ministry of Education and Center for Experimental Nuclear Medicine, School of Basic Medical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.

4. JYAMS PET Research and Development Limited, Nanjing, Jiangsu, China.

Funder

Huai'an Science and Technology Bureau

innovation key talents Project of the hospital

Publisher

XMLink

Subject

Radiology, Nuclear Medicine and imaging

Link

https://kjronline.org/pdf/10.3348/kjr.2022.1002

Reference100 articles.

1. Cancer statistics, 2022

2. 18F-Fluciclovine PET/CT in Therapeutic Decision Making for Prostate Cancer

3. Neuropilin-1 is upregulated in the adaptive response of prostate tumors to androgen-targeted therapies and is prognostic of metastatic progression and patient mortality

4. Neuroendocrine differentiation of prostate cancer leads to PSMA suppression

5. Development and prevalence of castration-resistant prostate cancer subtypes

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Carrier systems of radiopharmaceuticals and the application in cancer therapy;Cell Death Discovery;2024-01-09

2. New Oncologic Imaging Section in the Korean Journal of Radiology;Korean Journal of Radiology;2024

3. Promising therapy for neuroendocrine prostate cancer: current status and future directions;Therapeutic Advances in Medical Oncology;2024-01

4. Advances in Prostate Cancer Biomarkers and Probes;Cyborg and Bionic Systems;2024-01